Latka logo
Sanegene Bio logo

Sanegene Biorevenue

Woburn, MassachusettsFounded 2021CEO Weimin Wang

Sanegene Bio is a global biotech company dedicated to developing best-in-class RNA interference (RNAi) therapeutics aimed at addressing obesity, cardiometabolic, and autoimmune diseases.

sanegenebio.comLinkedInUpdated Sep 10, 2026
Annual revenue
$4.3M
Sep 2025EST
Employees
22
Sep 2025

Sanegene Bio revenue

Sanegene Bio has not published its revenue. Growjo puts it at about $4.3M a year (September 2025).

$0
$2M
$4M
$0
–
$4.3M
20212022–242025
ReportedEstimateFounded 2021 at $0; every reading has its own bar
As ofRevenueSource
Sep 2025$4.3MESTGrowjo estimate

Sanegene Bio CEO & employees

Weimin Wang is CEO of Sanegene Bio. Sanegene Bio has 22 employees (September 2025, LinkedIn).

0
10
20
22
2025
ReportedOne figure per year; a reported figure wins over an estimate

Sanegene Bio FAQ

What is Sanegene Bio's revenue?

Growjo estimates Sanegene Bio's revenue at about $4.3M a year (September 2025). The company hasn't published its own figure.

How many employees does Sanegene Bio have?

Sanegene Bio has 22 employees as of September 2025, according to LinkedIn.

Who is the CEO of Sanegene Bio?

Weimin Wang is the CEO of Sanegene Bio.

How this page is sourced

1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun Sanegene Bio? Join the podcast